Literature DB >> 17458608

Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.

Yoshiaki Murakami1, Kenichiro Uemura, Yasuo Hayashidani, Takeshi Sudo, Taijiro Sueda.   

Abstract

The aim of this study was to identify useful preoperative diagnostic findings indicative of malignant or invasive intraductal papillary-mucinous neoplasms (IPMN) of the pancreas to determine an optimal operative procedure for IPMN. Sixty-two IPMNs, which consisted of 29 adenomas, 10 borderline tumors, 11 adenocarcinomas in situ, and invasive adenocarcinomas were reviewed from 1990 to 2003. Preoperative predictive factors of malignant or invasive IPMN were analyzed among 10 factors by univariate and multivariate analysis. Diameter of the main pancreatic duct (> or =6 mm) and cytological examination of the pancreatic juice (the presence of malignant cells) were identified as independent predictive factors of malignant IPMN, and only cytological examination of the pancreatic juice (the presence of malignant cells) was identified as an independent predictor of invasive IPMN by multivariate analysis (P < 0.05). There was no recurrent disease in patients with adenoma and adenocarcinoma in situ, whereas recurrences occurred in 6 of 12 patients with invasive IPMN. Patient survival in noninvasive IPMN was significantly (P = 0.018) better than that in invasive IPMN (The overall 5-year survival rates were 87.2% and 49.2%, respectively). These results might be useful for selecting an optimal surgical procedure for IPMN.

Entities:  

Mesh:

Year:  2007        PMID: 17458608     DOI: 10.1007/s11605-006-0069-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

1.  Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.

Authors:  H Kondo; K Sugano; N Fukayama; K Hosokawa; H Ohkura; A Ohtsu; K Mukai; S Yoshida
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment.

Authors:  M Sugiyama; Y Atomi; A Kuroda
Journal:  Surgery       Date:  1997-09       Impact factor: 3.982

4.  Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.

Authors:  E Cuillerier; C Cellier; L Palazzo; J Devière; P Wind; F Rickaert; P H Cugnenc; M Cremer; J P Barbier
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

5.  Immunocytochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumors of the pancreas.

Authors:  T Iwao; A Tsuchida; K Hanada; N Eguchi; G Kajiyama; F Shimamoto
Journal:  Cancer       Date:  1997-06-25       Impact factor: 6.860

6.  Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.

Authors:  Massimo Raimondo; Issei Tachibana; Raul Urrutia; Lawrence J Burgart; Eugene P DiMagno
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

7.  Surgical treatment of intraductal papillary-mucinous tumors of the pancreas.

Authors:  N Kanazumi; A Nakao; T Kaneko; S Takeda; A Harada; S Inoue; T Nagasaka; N Nakashima
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

8.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

9.  Inferior head resection of the pancreas for intraductal papillary mucinous tumors.

Authors:  T Nakagohri; T Kenmochi; O Kainuma; Y Tokoro; S Kobayashi; T Asano
Journal:  Am J Surg       Date:  2000-06       Impact factor: 2.565

10.  Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.

Authors:  M Sugiyama; Y Izumisato; N Abe; T Masaki; T Mori; Y Atomi
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

View more
  17 in total

1.  Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Yoshio Yuasa; Taijiro Sueda
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

2.  Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms.

Authors:  Jin Hee Lee; Kyu Taek Lee; Jongwook Park; Sun Youn Bae; Kwang Hyuck Lee; Jong Kyun Lee; Kee-Taek Jang; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Jong Chul Rhee
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

3.  Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

4.  The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Kenjiro Kimura; Ryosuke Amano; Sadaaki Ymazoe; Go Ohira; Kohei Nishio; Kosei Hirakawa; Masaichi Ohira
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

5.  Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.

Authors:  Stefano Partelli; Carlos Fernandez-Del Castillo; Claudio Bassi; William Mantovani; Sarah P Thayer; Stefano Crippa; Cristina R Ferrone; Massimo Falconi; Paolo Pederzoli; Andrew L Warshaw; Roberto Salvia
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

6.  Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Authors:  Marco Niedergethmann; Robert Grützmann; Ralf Hildenbrand; Dag Dittert; Niloufar Aramin; Melanie Franz; Frank Dobrowolski; Stefan Post; Hans-Detlev Saeger
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience.

Authors:  L Calculli; R Pezzilli; C Brindisi; R Morabito; R Casadei; M Zompatori
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

8.  The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN.

Authors:  Rachel E Simpson; Eugene P Ceppa; Howard H Wu; Fatih Akisik; Michael G House; Nicholas J Zyromski; Attila Nakeeb; Mohammad A Al-Haddad; John M DeWitt; Stuart Sherman; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2019-01-02       Impact factor: 3.452

9.  Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2007-11-17       Impact factor: 3.452

Review 10.  [Computed tomography of pancreatic tumors].

Authors:  L Grenacher; M Klauss
Journal:  Radiologe       Date:  2009-02       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.